Results 261 to 270 of about 405,619 (302)
Some of the next articles are maybe not open access.
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2013
There is growing interest in the role of fibroblast growth factor 23 (FGF23) in various diseases of disordered mineral metabolism. In chronic kidney disease (CKD), where biochemical evidence of mineral disturbances is especially common, FGF23 measurement has been advocated as an early and sensitive marker for CKD-related bone disease. In this setting,
Edward R, Smith +2 more
openaire +2 more sources
There is growing interest in the role of fibroblast growth factor 23 (FGF23) in various diseases of disordered mineral metabolism. In chronic kidney disease (CKD), where biochemical evidence of mineral disturbances is especially common, FGF23 measurement has been advocated as an early and sensitive marker for CKD-related bone disease. In this setting,
Edward R, Smith +2 more
openaire +2 more sources
Determination of fibroblast growth factor 23
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2009Background Fibroblast growth factor 23 (FGF-23) is a recently discovered hormone, which plays a key role in phosphate regulation. To investigate whether FGF-23 can be determined reliably, we validated the three available FGF-23 assays. Methods Currently, two intact FGF-23 assays (Kainos; Immutopics) and one C-terminal FGF-23 assay (Immutopics) are ...
Heijboer, Annemieke C. +6 more
openaire +3 more sources
Fibroblast growth factor 23 and the heart
Current Opinion in Nephrology and Hypertension, 2012Elevated serum levels of the phosphaturic hormone fibroblast growth factor 23 (FGF23) are strongly associated with chronic kidney disease (CKD) progression and mortality, and are also independently associated with left ventricular hypertrophy, a major contributor to cardiovascular disease (CVD) and death in CKD patients.
openaire +2 more sources
Fibroblast Growth Factor 23 and Its Receptors
Therapeutic Apheresis and Dialysis, 2005Abstract: Fibroblast growth factor 23 (FGF23) is a circulating factor that plays critical roles in phosphate and vitamin D metabolism, as evidenced by the fact that FGF23 missense mutations cause autosomal dominant hypophosphatemic rickets (ADHR). Autosomal dominant hypophosphatemic rickets is characterized by hypophosphatemia with inappropriately ...
Xijie, Yu, Kenneth E, White
openaire +2 more sources
Fibroblast growth factor 23 and phosphate homeostasis
Current Opinion in Nephrology and Hypertension, 2019The current review highlights recent advances in the area of renal tubular phosphate transport and its regulation by fibroblast growth factor 23 (FGF23), a potent regulator of phosphate homeostasis.Recent studies demonstrate that FGF23 binds to both membrane and soluble form of α-klotho to activate FGF receptor signaling pathways.
Shanthi, Balani, Farzana, Perwad
openaire +2 more sources
Fibroblast Growth Factor 23 (FGF23) and the kidney
The International Journal of Artificial Organs, 2009Phosphate homeostasis in humans is a complex phenomenon involving the interplay of several different organs and circulating hormones. Among the latter, parathyroid hormone (PTH), and vitamin D3 (Vit D3) were thought to be the main regulators of serum phosphate concentration since they mediated the intestinal, renal and bone responses that follow ...
George, Tsagalis +3 more
openaire +2 more sources
Inherited fibroblast growth factor 23 excess
Best Practice & Research Clinical Endocrinology & MetabolismSyndromes of inherited fibroblast growth factor 23 (FGF-23) excess encompass a wide spectrum that includes X-linked hypophosphataemia (XLH), autosomal dominant and recessive forms of rickets as well as various syndromic conditions namely fibrous dysplasia/McCune Albright syndrome, osteoglophonic dysplasia, Jansen's chondrodysplasia and cutaneous ...
Kripa Elizabeth, Cherian +1 more
openaire +2 more sources
Fibroblast Growth Factor 23 and Klotho Are Present in the Growth Plate
Connective Tissue Research, 2013Regulation of phosphate homeostasis is essential for mineralization and enchondral ossification. Fibroblast growth factor 23 (FGF23) and its obligatory co-receptor Klotho (KL) play a key role in this process by influencing both renal phosphate reabsorption and vitamin D metabolism. In disease, excessive action of FGF23 leads to hypophosphatemic rickets,
Adalbert, Raimann +5 more
openaire +2 more sources